Explore 3 Stock Ideas & Industry Insights Download Free Report

BlackRock Health Sciences Trust II

Financial Services US BMEZ

14.32USD
-0.08(0.56%)

Last update at 2026-06-03T20:00:00Z

Day Range

14.2514.38
LowHigh

52 Week Range

12.4915.44
LowHigh

Fundamentals

  • Previous Close 14.40
  • Market Cap900.65M
  • Volume167469
  • P/E Ratio5.67
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM2.54

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 23.45M 20.02M -26.47108M 59.12M 1485.00M
Minority interest - - - - -
Net income 23.45M 20.02M -26.47108M 59.12M 1485.00M
Selling general administrative 0.36M 0.30M 0.36M 6.35M 1.50M
Selling and marketing expenses - - - - -
Gross profit 24.07M 28.87M -25.97095M 6.40M -
Reconciled depreciation - - - - -
Ebit 24.43M 22.03M -26.69956M 59.17M -
Ebitda 23.50M 20.02M -26.47108M 59.12M 1485.00M
Depreciation and amortization -0.92718M -2.00558M 0.23M -0.05394M -
Non operating income net other - - - - -
Operating income 0.93M 8.46M 1.54M 0.05M -
Other operating expenses 0.62M 6.19M 25.97M 0.54M -
Interest expense 0.00008M 0.00006M - - 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 0.01M -
Total revenue 24.07M 8.19M -25.97095M 59.66M 1486.87M
Total operating expenses 0.62M 0.39M -25.97095M 6.35M 1.87M
Cost of revenue 0.00008M -8.46414M - - -
Total other income expense net 22.53M 11.55M -28.01064M - -
Discontinued operations - - - - -
Net income from continuing ops - - - - 1485.00M
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 774.59M 596.10M - - 3087.75M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets -1.19548M -1.61505M - - -
Total liab 6.03M 7.97M - - 64.01M
Total stockholder equity 768.57M 588.14M - - 3023.74M
Deferred long term liab - - - - -
Other current liab -0.27806M -0.06069M - - -1.75952M
Common stock 942.10M 417.62M - - 1506.84M
Capital stock - - - - -
Retained earnings -173.53028M 170.52M - - 1516.90M
Other liab - - - - -
Good will - - - - -
Other assets -25.29198M 1.74M - - 19.40M
Cash 0.07M 0.00053M - - 0.03M
Cash and equivalents - - - - -
Total current liabilities - - - - 1.76M
Current deferred revenue - - - - -
Net debt -0.07134M -0.00053M - - -0.03369M
Short term debt 0.28M 0.06M - - -
Short long term debt - - - - -
Short long term debt total 0.28M 0.06M - - -
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets 26.56M -0.03784M - - 0.41M
Long term investments - - - - 3067.94M
Net tangible assets - - - - -
Short term investments 26.49M - - - -
Net receivables 1.20M 1.58M - - 0.38M
Long term debt - - - - -
Inventory - - - - -
Accounts payable - - - - 1.76M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 1506.84M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -773.32792M - - - -3067.94151M
Deferred long term asset charges - - - - -
Non current assets total 773.33M 594.40M - - 3067.94M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - - - -0.03555M -
Net borrowings - - - - -
Total cash from financing activities -65.51564M -32.02123M 0.88M 21.34M -96.98316M
Change to operating activities - - - - -
Net income 23.45M 20.02M -26.47108M 59.12M 1485.00M
Change in cash 0.00551M -0.00258M 0.00216M -0.21074M 10.18M
Begin period cash flow 0.00053M 0.00312M 0.00096M 0.21M 9.25M
End period cash flow 0.00605M 0.00053M 0.00312M 0.00096M 19.44M
Total cash from operating activities 65.52M 32.02M -0.87404M -21.55568M 107.17M
Issuance of capital stock - - - - -
Depreciation - - - - -
Other cashflows from investing activities - - - -0.03555M -
Dividends paid 35.92M 35.10M 32.73M 29.00M -96.98316M
Change to inventory - - - - -
Change to account receivables 0.22M -0.01782M -0.14689M 0.00545M -
Sale purchase of stock -29.53271M - - - -
Other cashflows from financing activities - -0.00050M -0.01993M 0.02M -
Change to netincome - - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.51M -0.76540M 0.33M 0.25M -66.75756M
Stock based compensation - - - - -
Other non cash items 41.56M 12.77M 25.27M -80.92121M -1311.07595M
Free cash flow 65.52M 32.02M -0.87404M -21.55568M 107.17M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
BMEZ
BlackRock Health Sciences Trust II
-0.08 0.56% 14.32 5.67 - 8.95 0.85 8.95
BLK
BlackRock Inc
-28.09 2.76% 990.87 26.25 19.57 6.33 2.90 6.35 17.13
BX
Blackstone Group Inc
-4.63 4.03% 110.28 33.20 20.12 11.05 11.56 9.14 15.74
BN
Brookfield Corp
-1.71 3.75% 43.88 94.78 11.89 1.35 2.37 4.58 10.79
IVSXF
Investor AB (publ)
- -% 40.41 20.83 - 0.88 1.11 10.01 1.68

Reports Covered

Stock Research & News

Key Executives

Name Title Year Born
Mr. Jeffrey Gene Lee Portfolio Mang. NA
Dr. Xiang Liu Ph.D. Portfolio Mang. NA
Dr. Xiang Liu Ph.D. Portfolio Manager NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.